U.S. Markets closed

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0300-0.0800 (-3.79%)
At close: 4:00PM EDT
2.0300 0.00 (0.00%)
After hours: 05:17PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.1100
Bid2.0300 x 29200
Ask2.0500 x 38500
Day's Range2.0300 - 2.1100
52 Week Range0.8730 - 4.5600
Avg. Volume2,647,930
Market Cap275.012M
Beta (5Y Monthly)1.53
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Insider Monkey

    10 Reddit’s WallStreetBets Stocks Under $5

    In this article, we discuss the 10 Reddit’s WallStreetBets stocks under $5. If you want to skip our detailed analysis of these stocks, go directly to the 5 Reddit’s WallStreetBets Stocks Under $5. Reddit forum WallStreetBets, with a user base of close to 11 million, is one of the hottest places in the finance world, […]

  • Zacks

    Citius (CTXR) Acquires Dr. Reddy's License for NHL Therapy

    Citius Pharmaceuticals (CTXR) acquires Dr. Reddy's exclusive license rights for E7777 to treat a rare form of NHL and other cancer indications.

  • Benzinga

    Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs

    Image by falco from Pixabay What happens when the one product keeping you alive becomes infected? Central venous catheters (CVCs) are important life lines for treating many patients, including those with cancer, coagulopathy, hemodialysis, and even those in intensive care units. These CVCs deliver vital fluids, blood, nutrition, medication, and hemodynamic therapies to critically ill patients. However, these devices, unfortunately, pose a significant risk of device-related infections, negating t